EE+ POEM Archive
Cefpodoxime should not be first-line treatment for acute uncomplicated cystitis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "Cefpodoxime Should Not Be First-line Treatment for Acute Uncomplicated Cystitis." EE+ POEM Archive, John Wiley & Sons, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/427528/all/Cefpodoxime_should_not_be_first_line_treatment_for_acute_uncomplicated_cystitis.
Cefpodoxime should not be first-line treatment for acute uncomplicated cystitis. In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2024. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/427528/all/Cefpodoxime_should_not_be_first_line_treatment_for_acute_uncomplicated_cystitis. Accessed December 10, 2024.
Cefpodoxime should not be first-line treatment for acute uncomplicated cystitis. (2024). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/427528/all/Cefpodoxime_should_not_be_first_line_treatment_for_acute_uncomplicated_cystitis
Cefpodoxime Should Not Be First-line Treatment for Acute Uncomplicated Cystitis [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2024. [cited 2024 December 10]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/427528/all/Cefpodoxime_should_not_be_first_line_treatment_for_acute_uncomplicated_cystitis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Cefpodoxime should not be first-line treatment for acute uncomplicated cystitis
ID - 427528
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/427528/all/Cefpodoxime_should_not_be_first_line_treatment_for_acute_uncomplicated_cystitis
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
